¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¿ëµµº°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2025-2032³â)
Global Duodenoscopes Market Size, Share & Trends Analysis Report By Application (Therapeutics/ Treatment and Diagnostics), By Product, By End Use, By Regional Outlook and Forecast, 2025 - 2032
»óǰÄÚµå : 1767810
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 244 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,021,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,025,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,436,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß¿¡ 5.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2032³â±îÁö 22¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶óÀÇ È®ÀåÀº ½ÃÀåÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ °è¼Ó ¼ºÀåÇÏ°í ¹ßÀüÇÔ¿¡ µû¶ó ½ÊÀÌÁöÀå ³»½Ã°æÀ» Æ÷ÇÔÇÑ Ã·´Ü ³»½Ã°æ µµ±¸¸¦ °®Ãá º´¿ø, Áø·á¼Ò ¹× Àü¹® ÀÇ·á ¼¾ÅͰ¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï±¹ ¸ðµÎ¿¡¼­ Á¤ºÎ¿Í ¹Î°£ ºÎ¹®Àº ÀÇ·á½Ã¼³ÀÇ ¾÷±×·¹À̵忡 ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, °íǰÁú ³»½Ã°æ ¼­ºñ½º Á¦°ø ´É·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÊ¿¡ µû¶ó ´õ ¸¹Àº ÀÇ·áÁøÀÌ Áø´Ü ¹× Ä¡·á¿¡ ½ÊÀÌÁöÀå ³»½Ã°æÀ» µµÀÔÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌó·³ ÀÇ·á ½Ã½ºÅÛÀÌ °è¼Ó ¹ßÀüÇϰí È®ÀåµÊ¿¡ µû¶ó ½ÊÀÌÁöÀå ³»½Ã°æ ¼ö¿ä´Â ÇÊ¿¬ÀûÀ¸·Î Áõ°¡ÇÏ¿© ¼¼°è ½ÃÀå È®´ë¿¡ ±â¿©ÇÒ °ÍÀÔ´Ï´Ù.

Äڷγª19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ Å« È¥¶õÀ» °¡Á®¿Ô½À´Ï´Ù. º´¿ø°ú ÀÇ·á ±â°üÀÌ ¼ö¸¹Àº Äڷγª19 È®ÁøÀÚ ´ëÀÀ¿¡ ÁýÁßÇϸ鼭 ³»½Ã°æ °Ë»ç¸¦ Æ÷ÇÔÇÑ ¸¹Àº ¼±ÅÃÀû ½Ã¼úÀÌ ¿¬±âµÇ°Å³ª ÁߴܵǾú½À´Ï´Ù. ±× °á°ú, ÁÖ·Î ¼ÒÈ­±â °èÅëÀÇ Áø´Ü ¹× Ä¡·á¿¡ »ç¿ëµÇ´Â ½ÊÀÌÁöÀå ³»½Ã°æ ¼ö¿ä°¡ ±Þ°ÝÈ÷ °¨¼ÒÇß½À´Ï´Ù. ÀÌó·³ Äڷγª19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

±×·¯³ª ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ¹°·ù ¹®Á¦ÀÔ´Ï´Ù. ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀº ±³Â÷ ¿À¿° ¹× °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ µµÀԵǾúÁö¸¸, »ó´çÇÑ ºñ¿ëÀÌ ¼ö¹ÝµË´Ï´Ù. ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀÇ ´Ü°¡´Â Àç»ç¿ë °¡´ÉÇÑ ¸ðµ¨º¸´Ù ÈξÀ ºñ½Î±â ¶§¹®¿¡ ƯÈ÷ ºñ¿ë¿¡ ¹Î°¨ÇÑ Áö¿ªÀÇ º´¿ø°ú ÀÇ·á ½Ã½ºÅÛ¿¡´Â ´õ ºñ½Ñ ¼±ÅÃÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¸¹Àº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ƯÈ÷ ½ÅÈï ½ÃÀå ¹× ¼Ò±Ô¸ð ÀÇ·á½Ã¼³ÀÇ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀÇ ³ôÀº ºñ¿ëÀº °æÁ¦Àû ºÎ´ãÀ¸·Î ÀÛ¿ëÇÏ¿© äÅÃÀ» °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ °æÁ¦Àû À庮Àº ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ äÅÃÀ» ¹æÇØÇÏ°í Æ¯Á¤ Áö¿ªÀÇ Àüü ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

Á¦Ç°º° Àü¸Á

Á¦Ç°º°·Î º¸¸é, ½ÃÀåÀº Àç»ç¿ëÇü°ú ÀÏȸ¿ë À¯ÇüÀ¸·Î ºÐ·ùµË´Ï´Ù. ÀÏȸ¿ë ºÎ¹®Àº 2024³â ½ÃÀå¿¡¼­ 15%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á ±â°üÀÌ °¨¿° °ü¸®¿Í ±³Â÷ ¿À¿° À§Çè °¨¼Ò¿¡ ÁßÁ¡À» µÎ¸é¼­ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ÀåÄ¡´Â º¹ÀâÇÑ Àç󸮰¡ ÇÊ¿äÇÏÁö ¾Ê¾Æ ȯÀÚ °£ º´¿øÃ¼ °¨¿° °¡´É¼ºÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

Àç»ç¿ë °¡´É º° Àü¸Á

Àç»ç¿ë °¡´ÉÇÑ ºÎ¹®Àº À¯¿¬¼º°ú °­¼º ºÎ¹®À¸·Î ¼¼ºÐÈ­µË´Ï´Ù. ¸®Áöµå ºÎ¹®Àº 2024³â ½ÃÀå ¼öÀÍ Á¡À¯À²ÀÇ 9%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯¿¬ÇÑ ³»½Ã°æ¸¸Å­ ³Î¸® º¸±ÞµÇÁö´Â ¾Ê¾ÒÁö¸¸, ¸®Áöµå ½ÊÀÌÁöÀå ³»½Ã°æÀº Á÷Áø Á¢±ÙÀ¸·Î ÃæºÐÇϰí À¯¿¬¼ºÀÌ ÃÖ¿ì¼± ¼øÀ§°¡ ¾Æ´Ñ ƯÁ¤ ÀÓ»ó ½Ã³ª¸®¿À¿¡¼­ ¿©ÀüÈ÷ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ³»½Ã°æÀº ±¸Á¶Àû ¾ÈÁ¤¼º°ú ³»±¸¼ºÀÌ ¶Ù¾î³ª ƯÁ¤ Áø´Ü ÀýÂ÷¿¡¼­ À¯¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿ëµµº° Àü¸Á

¿ëµµº°·Î ½ÃÀåÀº Áø´Ü°ú Ä¡·á/Ä¡·á·Î ºÐ·ùµË´Ï´Ù. Ä¡·á/Ä¡·á ºÎ¹®Àº 2024³â ½ÃÀåÀÇ 68%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ´ã°ü ½ºÅÙÆ® »ðÀÔ, °á¼® Á¦°Å, °ý¾à±Ù Àý°³¼ú µî ´Ù¾çÇÑ Ä¡·áÀû °³ÀÔ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ³»½Ã°æ °Ë»çÀÇ ¹ßÀü°ú ÇÔ²² ½ÊÀÌÁöÀå³»½Ã°æÀÇ Ä¡·áÀû ¿ëµµ°¡ È®´ëµÇ°í ÀÖÀ¸¸ç, ƯÈ÷ º¹ÀâÇÑ ÃéÀå ¹× ´ãµµ ÁúȯÀÇ °ü¸®¿¡¼­ ±× Ȱ¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº° Àü¸Á

¿ëµµº°·Î º¸¸é, ½ÃÀåÀº º´¿ø°ú ¿Ü·¡È¯ÀÚ ½Ã¼³·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù. ¿Ü·¡È¯ÀÚ ½Ã¼³ ºÎ¹®Àº 2024³â ½ÃÀå Á¡À¯À² 53%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³Àº ºñ¿ë È¿À²¼º, ªÀº ´ë±â ½Ã°£, ºü¸¥ ȯÀÚ Ã³¸® ½Ã°£ µîÀÇ ÀÌÀ¯·Î ÀÏ»óÀûÀÎ Àúħ½ÀÀû ³»½Ã°æ °Ë»ç¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ ¼±Åõǰí ÀÖ½À´Ï´Ù. ½ÊÀÌÁöÀå ³»½Ã°æ ±â¼úÀÇ ¹ßÀü°ú ÀÔ¿ø Ä¡·á¿¡¼­ ¿Ü·¡ Ä¡·á·Î ÀüȯÇÏ´Â Ãß¼¼°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ÀÌ·¯ÇÑ ½Ã¼³µéÀº ¾çÁúÀÇ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

Áö¿ªº° Àü¸Á

Áö¿ªº°·Î´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA(¶ó ¸Þ¸®¾Æ, ¶ó ¸Þ¸®¾Æ) µî 4°³ Áö¿ªÀ¸·Î ½ÃÀåÀ» ºÐ¼®Çß½À´Ï´Ù. À¯·´Àº 2024³â ½ÃÀåÀÇ 30%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ªÀº °í·ÉÈ­ Àα¸ Áõ°¡, ¼ÒÈ­±â Áúȯ ¹ß»ý·ü Áõ°¡, ³»½Ã°æ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. À¯·´ ±¹°¡µé¿¡¼­´Â Àúħ½ÀÀû Áø´Ü ¹× Ä¡·á ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÊÀÌÁöÀå ³»½Ã°æÀÌ ÀÇ·á ÇöÀå¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ¿ëµµº°

Á¦5Àå ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ½ÊÀÌÁöÀå ³»½Ã°æ ½ÃÀå : Áö¿ªº°

Á¦8Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Duodenoscopes Market size is expected to reach $2.29 billion by 2032, rising at a market growth of 5.1% CAGR during the forecast period.

The United States, in particular, has a well-established network of hospitals and endoscopy centers and favorable reimbursement policies that support using duodenoscopes in diagnostic and therapeutic procedures. Furthermore, strong regulatory oversight and continuous efforts to enhance patient safety have spurred demand for reusable and disposable duodenoscope models across the region. Thus, the North America segment recorded 44% revenue share in the market in 2024. This dominance can be attributed to the region's advanced healthcare infrastructure, high adoption rate of innovative medical technologies, and the increasing prevalence of gastrointestinal disorders.

Minimally invasive endoscopic procedures have become the standard in modern healthcare, driving the demand for duodenoscopes. These procedures offer many advantages over traditional surgical approaches, including reduced recovery times, minimal scarring, and a lower risk of complications. Duodenoscopes, which are essential for procedures such as endoscopic retrograde cholangiopancreatography (ERCP), play a critical role in enabling physicians to access and treat the duodenum, bile ducts, and pancreas without the need for large incisions. In conclusion, the growing preference for minimally invasive endoscopic procedures drives the market's growth.

Additionally, the expansion of healthcare infrastructure is a pivotal driver of the market. As healthcare systems worldwide continue to grow and evolve, more hospitals, clinics, and specialized healthcare centers are equipped with advanced endoscopic tools, including duodenoscopes. In both developed and emerging economies, governments and private sectors are investing heavily in upgrading healthcare facilities, increasing their capacity to deliver high-quality endoscopic services. Expanded access to modern medical technologies enables more healthcare professionals to incorporate duodenoscopes into their diagnostic and therapeutic practices. Thus, as healthcare systems continue to evolve and expand, the demand for duodenoscopes will inevitably grow, contributing to global market expansion.

The COVID-19 pandemic significantly disrupted the market. As hospitals and healthcare facilities shifted their focus toward managing the overwhelming number of COVID-19 cases, elective procedures, including many endoscopic examinations, were postponed or cancelled. This led to a sharp decline in the demand for duodenoscopes, which are primarily used in gastrointestinal diagnostic and therapeutic procedures. Thus, the COVID-19 pandemic had a negative impact on the market.

However, one of the key restraints limiting the growth of the market is the high cost and logistical challenges associated with single-use duodenoscopes. While single-use duodenoscopes have been introduced to reduce the risk of cross-contamination and infection, they come with a significant price tag. The cost per unit of a single-use duodenoscope is considerably higher than reusable models, making it a more expensive option for hospitals and healthcare systems, particularly in cost-sensitive regions. For many healthcare providers, especially those in emerging markets or smaller healthcare facilities, the high expense of single-use duodenoscopes poses a financial burden that could lead to reduced adoption. Therefore, this economic barrier could hinder the adoption of single-use duodenoscopes, impacting the overall growth of the duodenoscope market in certain regions.

Product Outlook

Based on product, the market is characterized into reusable and disposable. The disposable segment procured 15% revenue share in the market in 2024. The demand for disposable duodenoscopes has risen as healthcare institutions focus more on infection control and reducing cross-contamination risks. Single-use devices eliminate the need for complex reprocessing and minimize the chances of patient-to-patient transmission of pathogens.

Reusable Outlook

The reusable segment is further subdivided into flexile and rigid. The rigid segment held 9% revenue share in the market in 2024. Although less commonly used than flexible scopes, rigid duodenoscopes remain relevant in specific clinical scenarios where straight access is sufficient, and flexibility is not a primary requirement. These scopes are known for their structural stability and durability, which can be beneficial in certain diagnostic procedures.

Application Outlook

On the basis of application, the market is classified into diagnostics and therapeutics/ treatment. The therapeutics/ treatment segment recorded 68% revenue share in the market in 2024. These instruments are vital in various therapeutic interventions, including bile duct stent placements, stone extractions, and sphincterotomies. As endoscopic procedures continue to evolve, the use of duodenoscopes in therapeutic applications has expanded, especially in managing complex pancreatic and biliary diseases.

End Use Outlook

By end use, the market is divided into hospitals and outpatient facilities. The outpatient facilities segment garnered 53% revenue share in the market in 2024. These centers are increasingly preferred for less invasive and routine endoscopic procedures due to their cost-effectiveness, shorter wait times, and quicker patient turnaround. Advances in duodenoscope technology and the growing trend of shifting procedures from inpatient to outpatient settings have made it feasible for these facilities to offer high-quality care.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment witnessed 30% revenue share in the market in 2024. The region benefits from a growing elderly population, rising incidence of digestive disorders, and increasing investment in endoscopic technologies. European countries emphasize minimally invasive diagnostic and treatment techniques, which support using duodenoscopes across healthcare settings.

List of Key Companies Profiled

Global Duodenoscopes Market Report Segmentation

By Application

By Product

By End Use

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Duodenoscopes Market by Application

Chapter 5. Global Duodenoscopes Market by Product

Chapter 6. Global Duodenoscopes Market by End Use

Chapter 7. Global Duodenoscopes Market by Region

Chapter 8. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â